These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 803324)

  • 1. Treatment of coexistent angina pectoris and hypertension with prindolol.
    Leary WP; Asmal AC
    S Afr Med J; 1975 Jan; 49(1):11-2. PubMed ID: 803324
    [No Abstract]   [Full Text] [Related]  

  • 2. Propranolol and LB 46 (prinodolol) in angina pectoris. A comparative long-term ergometric study.
    Arstila M; Kallio V; Wendelin H
    Ann Clin Res; 1973 Apr; 5(2):91-100. PubMed ID: 4201295
    [No Abstract]   [Full Text] [Related]  

  • 3. Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests.
    Bjerle P; Jacobsson KA
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):101-16. PubMed ID: 4218804
    [No Abstract]   [Full Text] [Related]  

  • 4. [Beta-blockader, pindolol, in the therapy of angina pectoris; a report on a multicentric controlled study].
    Lang E; Fitscha P; Schiess W
    Wien Med Wochenschr; 1979 Sep; 129(17):484-8. PubMed ID: 120078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separate and combined effects of pindolol and isosorbide dinitrate in standardized exercise tests of patients with angina pectoris.
    Zetterquist S; Furberg C; Ringqvist I; Söderholm B
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):139-48. PubMed ID: 803427
    [No Abstract]   [Full Text] [Related]  

  • 6. [The cardiotropic effect of the beta receptor blockader Prindolol].
    Fiegel G
    Med Welt; 1975 Oct; 26(43):1989-9. PubMed ID: 1196090
    [No Abstract]   [Full Text] [Related]  

  • 7. A double blind study of Visken LB-46, in the treatment of angina pectoris.
    Nair DV
    Indian Heart J; 1972 Jun; 24():Suppl 1:183-91. PubMed ID: 4581426
    [No Abstract]   [Full Text] [Related]  

  • 8. A double blind drug trial of LB-46 (visken) in angina pectoris.
    Sainani GS; Mukherjee AK
    Indian Heart J; 1972 Jun; 24():Suppl 1:192-6. PubMed ID: 4581427
    [No Abstract]   [Full Text] [Related]  

  • 9. Double-blind factorial trial of prindolol and hydrochlorothiazide in hypertension.
    Chalmers JP; Korner PI; Tiller DJ; Bune AJ; Steiner JD; West MJ; Wing LM; Uther JF
    Med J Aust; 1976 May; 1(18):650-3. PubMed ID: 781495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenylamine lactate in the treatment of angina pectoris.
    Leary WP; Asmal AC; Williams P
    Curr Ther Res Clin Exp; 1976 Feb; 19(2):180-4. PubMed ID: 813955
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris.
    Dwyer EM; Pepe AJ; Pinkernell BH
    Am Heart J; 1982 May; 103(5):830-3. PubMed ID: 6803556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of transdermal nitroglycerin in the treatment of patients with stable angina pectoris and its effect on selected hemodynamic parameters].
    Trojnar R; Rymar B; Wysokiński A; Markiewicz M; Wójcik J
    Wiad Lek; 1988 Aug; 41(15):977-83. PubMed ID: 3149817
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 14. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
    Waal-Manning HJ; Simpson FO
    N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769
    [No Abstract]   [Full Text] [Related]  

  • 15. A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial).
    Srivastava BN; Jain PC; Vyas GP
    Indian Heart J; 1972 Jun; 24():Suppl 1:203-4. PubMed ID: 4581428
    [No Abstract]   [Full Text] [Related]  

  • 16. Verapamil in chronic stable angina: a controlled study with computerized multistage treadmill exercise.
    Bala Subramanian V; Lahiri A; Parmasivan R; Raftery EB
    Clin Invest Med; 1980; 3(1-2):111-8. PubMed ID: 6781805
    [No Abstract]   [Full Text] [Related]  

  • 17. A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris.
    Hebb AR; Godwin TF; Gunn RW
    Can Med Assoc J; 1968 Feb; 98(5):246-51. PubMed ID: 4965821
    [No Abstract]   [Full Text] [Related]  

  • 18. LB-46 in angina pectoris. A critique of anti-anginal drug assessment.
    Ganeshan KP; Xavier KB
    Indian Heart J; 1972 Jun; 24():Suppl 1:197-20. PubMed ID: 4147275
    [No Abstract]   [Full Text] [Related]  

  • 19. [Stress tests limited by the symptoms in the evaluation of drug treatment of angina pectoris].
    Broustet JP; Pic A; Laurentjoye P; Douard H; Mora B
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():17-24. PubMed ID: 6134507
    [No Abstract]   [Full Text] [Related]  

  • 20. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
    Antalóczy Z; Kekes E
    Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.